-
3
-
-
77954496048
-
Malaria control beyond 2010
-
Newman RD. Malaria control beyond 2010. BMJ 2010; 340:c2714.
-
(2010)
BMJ
, vol.340
, pp. c2714
-
-
Newman, R.D.1
-
4
-
-
77955491116
-
Demand for malaria drug soars
-
Noorden RV. Demand for malaria drug soars. Nature 2010; 466:672-3.
-
(2010)
Nature
, vol.466
, pp. 672-673
-
-
Noorden, R.V.1
-
5
-
-
77955951674
-
Arterolane, a new synthetic trioxolane for treatment of uncomplicated plasmodium falciparum malaria: A phase II, multicenter, randomized, dose-finding clinical trial
-
Valecha N, Looareesuwan S, Martensson A, et al. Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial. Clin Infect Dis 2010; 51:684-91.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 684-691
-
-
Valecha, N.1
Looareesuwan, S.2
Martensson, A.3
-
7
-
-
0003484310
-
-
U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM)
-
Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), 2001.
-
(2001)
Guidance for Industry, Bioanalytical Method Validation
-
-
-
8
-
-
84864962615
-
Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated plasmodium falciparum malaria: A comparative, multicenter, randomized clinical trial
-
Valecha N, Krudsood S, Tangpukdee N, et al. Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial. Clin Infect Dis 2012; 55:663-71.
-
(2012)
Clin Infect Dis
, vol.55
, pp. 663-671
-
-
Valecha, N.1
Krudsood, S.2
Tangpukdee, N.3
-
9
-
-
77952303346
-
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated plasmodium falciparum malaria: A randomised non-inferiority trial
-
Tshefu AK, Gaye O, Kayentao K, et al. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet 2010; 375:1457-67.
-
(2010)
Lancet
, vol.375
, pp. 1457-1467
-
-
Tshefu, A.K.1
Gaye, O.2
Kayentao, K.3
-
10
-
-
65549137143
-
The effect of varying analytical methods on estimates of anti-malarial clinical efficacy
-
Verret WJ, Dorsey G, Nosten F, Price RN. The effect of varying analytical methods on estimates of anti-malarial clinical efficacy. Malar J 2009; 8:77.
-
(2009)
Malar J
, vol.8
, pp. 77
-
-
Verret, W.J.1
Dorsey, G.2
Nosten, F.3
Price, R.N.4
-
11
-
-
79959612992
-
-
Geneva, Switzerland: World Health Organization, Accessed 9 February 2016
-
WHO. Global Plan for Artemisinin Resistance Containment (GPARC). Geneva, Switzerland: World Health Organization, 2011. Available at: http://www.who.int/malaria/publications/atoz/artemisinin-resistance-containment-2011.pdf. Accessed 9 February 2016.
-
(2011)
Global Plan for Artemisinin Resistance Containment (GPARC)
-
-
WHO1
-
12
-
-
33846592758
-
Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277)
-
Uhlemann AC, Wittlin S, Matile H, Bustamante LY, Krishna S. Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277). Antimicrob Agents Chemother 2007; 51:667-72.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 667-672
-
-
Uhlemann, A.C.1
Wittlin, S.2
Matile, H.3
Bustamante, L.Y.4
Krishna, S.5
-
13
-
-
33748036039
-
In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of plasmodium falciparum
-
Maerki S, Brun R, Charman SA, Dorn A, Matile H, Wittlin S. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum. J Antimicrob Chemother 2006; 58:52-8.
-
(2006)
J Antimicrob Chemother
, vol.58
, pp. 52-58
-
-
Maerki, S.1
Brun, R.2
Charman, S.A.3
Dorn, A.4
Matile, H.5
Wittlin, S.6
-
14
-
-
38349174133
-
Safety, tolerability, and single- and multipledose pharmacokinetics of piperaquine phosphate in healthy subjects
-
Ahmed T, Sharma P, Gautam A, et al. Safety, tolerability, and single- and multipledose pharmacokinetics of piperaquine phosphate in healthy subjects. J Clin Pharmacol 2008; 48:166-75.
-
(2008)
J Clin Pharmacol
, vol.48
, pp. 166-175
-
-
Ahmed, T.1
Sharma, P.2
Gautam, A.3
-
15
-
-
80054771436
-
Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. Falciparum malaria
-
Gautam A, Ahmed T, Sharma P, et al. Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. falciparum malaria. J Clin Pharmacol 2011; 51:1519-28.
-
(2011)
J Clin Pharmacol
, vol.51
, pp. 1519-1528
-
-
Gautam, A.1
Ahmed, T.2
Sharma, P.3
-
16
-
-
77955606614
-
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
-
Valecha N, Phyo AP, Mayxay M, et al. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. PLoS One 2010; 5:e11880.
-
(2010)
PLoS One
, vol.5
, pp. e11880
-
-
Valecha, N.1
Phyo, A.P.2
Mayxay, M.3
-
17
-
-
68149158508
-
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: A prospective multi-centre individual patient data analysis
-
Zwang J, Ashley EA, Karema C, et al. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One 2009; 4:e6358.
-
(2009)
PLoS One
, vol.4
, pp. e6358
-
-
Zwang, J.1
Ashley, E.A.2
Karema, C.3
-
18
-
-
23244447395
-
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria
-
Ashley EA, McGready R, Hutagalung R, et al. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis 2005; 41:425-32.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 425-432
-
-
Ashley, E.A.1
McGready, R.2
Hutagalung, R.3
-
19
-
-
35748964160
-
Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria
-
Mytton OT, Ashley EA, Peto L, et al. Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria. Am J Trop Med Hyg 2007; 77:447-50.
-
(2007)
Am J Trop Med Hyg
, vol.77
, pp. 447-450
-
-
Mytton, O.T.1
Ashley, E.A.2
Peto, L.3
-
20
-
-
34249862105
-
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: A randomized trial
-
Kamya MR, Yeka A, Bukirwa H, et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials 2007; 2:e20.
-
(2007)
PLoS Clin Trials
, vol.2
, pp. e20
-
-
Kamya, M.R.1
Yeka, A.2
Bukirwa, H.3
-
21
-
-
0346057805
-
Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in cambodian children and adults with malaria
-
Karunajeewa H, Lim C, Hung TY, et al. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br J Clin Pharmacol 2004; 57:93-9.
-
(2004)
Br J Clin Pharmacol
, vol.57
, pp. 93-99
-
-
Karunajeewa, H.1
Lim, C.2
Hung, T.Y.3
-
22
-
-
0142209158
-
Drug induced QT prolongation and torsades de pointes
-
Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003; 89:1363-72.
-
(2003)
Heart
, vol.89
, pp. 1363-1372
-
-
Yap, Y.G.1
Camm, A.J.2
-
23
-
-
35848930611
-
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drugresistant malaria
-
Price RN, Hasugian AR, Ratcliff A, et al. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drugresistant malaria. Antimicrob Agents Chemother 2007; 51:4090-7.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 4090-4097
-
-
Price, R.N.1
Hasugian, A.R.2
Ratcliff, A.3
|